期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 572, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ijpharm.2019.118771
关键词
Nanostructured lipid carriers; Antifungal; Ocular fungal pharmacotherapy; Design of experiments; IVIVC; Drug delivery; PEGylation
资金
- National Institute of General Medical Sciences [P30GM122733]
- National Eye Institute, National Institutes of Health [1R01EY022120-01A1]
The current study sought to formulate, optimize, and stabilize amphotericin B (AmB) loaded PEGylated nanostructured lipid carriers (NLC) and to study its ocular biodistribution following topical instillation. AmB loaded PEGylated NLC (AmB-PEG-NLC) were fabricated by hot-melt emulsification followed by high-pressure homogenization (HPH) technique. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)] (mPEG-2K-DSPE) was used for surface PEGylation. mPEG-DSPE with different PEG molecular weight, 1 K, 2 K, 5 K, 10 K, and 20 K, were screened for formulation stability. Furthermore, the AmB loaded PEGylated (2K) NLC (AmB-PEG2K-NLC) was optimized using Box-Behnken design with respect to the amount of AmB, castor oil, mPEG-2K-DSPE, and number of high-pressure homogenization cycles as the factors; particle size, zeta potential, PDI, entrapment efficiency, and loading efficiency as responses. Stability of the optimized AmBPEG2K-NLC was assessed over 4 weeks, at 4 degrees C as well as 25 degrees C and effect of autoclaving was also evaluated. AmB-PEG2K-NLC were tested for their in vitro antifungal activity against Candida albicans (ATCC 90028), AmB resistant Candida albicans (ATCC 200955) and Aspergillus fumigants (ATCC 204305). Cytotoxicity of AmB-PEG2KNLC was studied in human retinal pigmented epithelium cells. In vivo ocular biodistribution of AmB was evaluated in rabbits, following topical application of PEGylated NLCs or marketed AmB preparations. PEGylation with mPEG-2K-DSPE prevented leaching of AmB and increased the drug load significantly. The optimized formulation was prepared with a particle size of 218 +/- 5 nm; 0.3 +/- 0.02 PDI, 4.6 +/- 0.1% w/w drug loading, and 92.7 +/- 2.5% w/w entrapment efficiency. The optimized colloidal dispersions were stable for over a month, at both 4 degrees C and 25 degrees C. AmB-PEG2K-NLCs showed significantly (p < 0.05) better antifungal activity in both wildtype and AmB resistant Candida strains and, was comparable to, or better than, commercially available parenteral AmB formulations like Fungizone (TM) and AmBisome (R). AmB-PEG2K-NLC did not show any toxicity up to a highest concentration of 1% (v/v) (percent formulation in medium). Following topical instillation, AmB was detected in all the ocular tissues tested and statistically significant (p > 0.05) difference was not observed between the formulations tested. An optimized autoclavable and effective AmB-PEG2K-NLC ophthalmic formulation with at least one-month stability, in the reconstituted state, has been developed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据